UNITAID allocates $3.9 million for EOSCAPE-based molecular diagnostics in high-disease-burden countries
0 0
Strong NGO support cited for system's capacity for multiplexing and exceptionally high performance sample prep module
Featured Presentation at Sample Preparation Conference Highlights Wave 80’s Technological Leadership
0 0
Dr. Shan Gao, a senior member of Wave 80’s technical staff, to speak on high-efficiency extraction of genomic material from challenging samples without centrifugation.
Dr. Daniel Laser, Wave 80’s Chief Executive Officer and President, will discuss major recent advances in the company’s bioassay technology as part of an invited talk at the upcoming Semicon [...]
Wave 80 Scientist Co-Authors Journal Article Highlighting Challenges, Opportunities in Clinical Laboratory Testing for Infectious Disease
0 0
Dr. Laura Mazzola, Wave 80’s Senior Vice President of Global Initiatives, co-authors analysis of impact and opportunities for new diagnostics technologies.
Next-generation point-of-care molecular diagnostic system meets challenges of detecting acute infections, monitoring recipients of candidate vaccines, and diagnosing infants born to HIV-infected [...]
Talk will highlight evolving challenges and opportunities in global health
Collaboration to explore new ways of using magnetic detection in high-performance enclosed-cartridge-format assays.
Exploring new methods of optimizing therapy.
Wave 80 and University of Pennsylvania initiate new program in biomarker-based stroke patient stratification
0 0
New approach to guiding therapy holds promise for improving patient outcomes in ischemic stroke.
With NIH support, initiative seeks to develop innovative new molecular diagnostics tools for guiding vaccine development and antiretroviral therapy